دورية أكاديمية
أعرض في EDS

Prevalence of comorbidities in deceased patients with COVID-19: A systematic review.

التفاصيل البيبلوغرافية
العنوان: Prevalence of comorbidities in deceased patients with COVID-19: A systematic review.
المؤلفون: Justino DCP; Department of Public Health, Federal University of Rio Grande do Norte, Brazil., Silva DFO; Department of Public Health, Federal University of Rio Grande do Norte, Brazil., Costa KTDS; Nursing Department, Federal University of Rio Grande do Norte, Brazil., de Morais TNB; Nursing Department, Federal University of Rio Grande do Norte, Brazil., de Andrade FB; Nursing Department, Federal University of Rio Grande do Norte, Brazil.
المصدر: Medicine [Medicine (Baltimore)] 2022 Sep 23; Vol. 101 (38), pp. e30246.
نوع المنشور: Journal Article; Review; Systematic Review
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
مواضيع طبية MeSH: COVID-19*/epidemiology, Comorbidity ; Humans ; Prevalence ; SARS-CoV-2
مستخلص: Background: In December 2019, a new disease, coronavirus disease (COVID-19), emerged, which put several countries on a state of alert. Because it is a novel virus, several aspects and factors that contribute to the evolution of pathogenesis are still unknown and need to be better understood. Therefore, a systematic review is necessary to investigate the association between COVID-19 infection and chronic nontransmissible disease in patients who have died of COVID-19.
Methods: This was a systematic review of the literature for observational studies published between December 2019 and September 2020. The protocol for this systematic review was registered in the International prospective register of systematic reviews (PROSPERO) under the number CRD42020176249.
Results: In the 31 studies analyzed, a total of 421,872 (100%) patients were infected with COVID-19, and, of these, 45,399 (10.8%) died. The 3 most prevalent comorbidities were hypertension, diabetes mellitus, and respiratory diseases, respectively. The cure/recovery rate was 89.2% (376,473).
Conclusion: This review revealed a high percentage of comorbidities in the patients with COVID-19, especially those who died.
Competing Interests: The authors have no funding and conflicts of interest to disclose.
(Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.)
References: Lancet Respir Med. 2020 Apr;8(4):420-422. (PMID: 32085846)
Diabet Med. 2020 May;37(5):723-725. (PMID: 32242990)
Circ Res. 2017 Sep 1;121(6):677-694. (PMID: 28860318)
Glob Heart. 2018 Sep;13(3):143-163. (PMID: 30301680)
Lancet. 2020 Mar 7;395(10226):809-815. (PMID: 32151335)
JAMA. 2020 Apr 14;323(14):1406-1407. (PMID: 32083643)
Diabetes Res Clin Pract. 2020 Apr;162:108142. (PMID: 32278764)
Nat Rev Immunol. 2020 Jun;20(6):355-362. (PMID: 32376901)
Diabetes Metab Syndr. 2020 May - Jun;14(3):247-250. (PMID: 32247212)
Lancet. 2016 Apr 9;387(10027):1513-1530. (PMID: 27061677)
Circulation. 2020 May 19;141(20):1648-1655. (PMID: 32200663)
Emerg Microbes Infect. 2020 Dec;9(1):757-760. (PMID: 32228222)
Diabetes Metab Syndr. 2020 May - Jun;14(3):211-212. (PMID: 32172175)
N Engl J Med. 2020 Jun 18;382(25):e102. (PMID: 32356626)
Diabetes Res Clin Pract. 2018 Apr;138:271-281. (PMID: 29496507)
Circulation. 2016 Aug 9;134(6):441-50. (PMID: 27502908)
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):303-310. (PMID: 32298981)
تواريخ الأحداث: Date Created: 20221005 Date Completed: 20221007 Latest Revision: 20230804
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9508958
DOI: 10.1097/MD.0000000000030246
PMID: 36197209
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-5964
DOI:10.1097/MD.0000000000030246